[The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
The comparative study of the effectiveness of immune immunoglobulin and bifidumbacterin for the correction of dysbiotic microflora in the intestine of premature born children with infectious inflammatory diseases. Immune lactoglobulin was administered orally to 37 children in a dose of 500 mg/kg twice a day for 1-3 weeks. The preparation facilitated the rapid and stable normalization of disturbances in the intestinal biocenosis in 86.5% of newborns. The elimination of opportunistic lactose-negative enterobacteria, Pseudomonas aeruginosa hemolytic forms of Escherichia from the digestive tract and the stimulation of the multiplication of lactic acid bacteria were noted. The treatment of newborns with immune lactoglobulin was found to give a more pronounced corrective effect with respect of intestinal microflora than the use of bifidumbacterin according to the traditional scheme.
Kushnareva
M V
MV
Keshishian
E S
ES
Soboleva
S V
SV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001688:Biological Products / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005243:Feces / Q000382:microbiology; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000382:microbiology; D007782:Lactoglobulins / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D001688:Biological Products; D007782:Lactoglobulins; C010546:bifidobacterin
Effektivnost' primeneniia preparata immunnogo laktoglobulina dlia korrektsii disbakterioza kishechnika u novorozhdennykh deteĭ.